Cargando…

Lipoprotein(a) and Cardiovascular Outcomes after Revascularization of Carotid and Lower Limbs Arteries

Background: Despite high-intensity lipid-lowering therapy, there is a residual risk of cardiovascular events that could be associated with lipoprotein(a) (Lp(a)). It has been shown that there is an association between elevated Lp(a) level and cardiovascular outcomes in patients with coronary heart d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ezhov, Marat V., Tmoyan, Narek A., Afanasieva, Olga I., Afanasieva, Marina I., Pokrovsky, Sergei N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916698/ https://www.ncbi.nlm.nih.gov/pubmed/33578899 http://dx.doi.org/10.3390/biom11020257

Ejemplares similares

Low Molecular Weight Apolipoprotein(a) Phenotype Rather Than Lipoprotein(a) Is Associated With Coronary Atherosclerosis and Myocardial Infarction
por: Afanasieva, Olga I., et al.
Publicado: (2022)

Lipoprotein(a), Immunity, and Inflammation in Polyvascular Atherosclerotic Disease
por: Tmoyan, Narek A., et al.
Publicado: (2021)

Lipoprotein(a), Immune Cells and Cardiovascular Outcomes in Patients with Premature Coronary Heart Disease
por: Afanasieva, Olga I., et al.
Publicado: (2022)

Effect of Evolocumab on Lipoprotein(a) and PCSK9 in Healthy Individuals with Elevated Lipoprotein(a) Level
por: Afanasieva, Olga, et al.
Publicado: (2020)

Elevated Lipoprotein(a) Level Influences Familial Hypercholesterolemia Diagnosis
por: Chubykina, Uliana V., et al.
Publicado: (2022)

Matrix Metalloproteinase 9 as a Predictor of Coronary Atherosclerotic Plaque Instability in Stable Coronary Heart Disease Patients with Elevated Lipoprotein(a) Levels
por: Ezhov, Marat, et al.
Publicado: (2019)

Lipoprotein(a) and Low-Molecular-Weight Apo(a) Phenotype as Determinants of New Cardiovascular Events in Patients with Premature Coronary Heart Disease
por: Afanasieva, Olga I., et al.
Publicado: (2023)

Lipoprotein(a) and Its Autoantibodies in Association with Calcific Aortic Valve Stenosis
por: Burdeynaya, Anna L., et al.
Publicado: (2023)

The Association of Lipoprotein(a) and Circulating Monocyte Subsets with Severe Coronary Atherosclerosis
por: Afanasieva, Olga I., et al.
Publicado: (2021)

Hyperlipoproteinemia(a) and Severe Coronary Artery Lesion Types
por: Ilina, Larisa N., et al.
Publicado: (2022)

The Concentration of PCSK9-Lp(a) Complexes and the Level of Blood Monocytes in Males with Coronary Atherosclerosis
por: Filatova, Anastasiia Yu., et al.
Publicado: (2023)

Lipoprotein(a) Lowering—From Lipoprotein Apheresis to Antisense Oligonucleotide Approach
por: Greco, Maria Francesca, et al.
Publicado: (2020)

A Sorbent with Synthetic Ligand for Removing Pro-atherogenic and Pro-inflammatory Components from Human Blood Plasma
por: Dmitrieva, O. A., et al.
Publicado: (2021)

Role of the APOE polymorphism in carotid and lower limb revascularization: A prospective study from Southern Italy
por: Mastroianno, Sandra, et al.
Publicado: (2017)

Association Between Statin Use and Cardiovascular Events After Carotid Artery Revascularization
por: Hussain, Mohamad A., et al.
Publicado: (2018)

Ophthalmic Artery Occlusion After Carotid Revascularization
por: Yi, Yeon Jin, et al.
Publicado: (2013)

Endovascular revascularization of chronic total arterial occlusion of the lower limb using the SAFARI technique
por: Huillca, Miguel Alonso-Rojas, et al.
Publicado: (2021)

Revascularization Outcomes in COVID-19 Patients With Acute Lower Limb Ischemia
por: Desantis, Claudio, et al.
Publicado: (2022)

Percutaneous access of an intraoperatively recanalized mid-superficial femoral artery for distal lower limb revascularization
por: Karelis, Angelos, et al.
Publicado: (2023)

Risk Factors for Incident Carotid Artery Revascularization among Older Adults: The Cardiovascular Health Study
por: Garg, Parveen K., et al.
Publicado: (2016)

Transcarotid artery revascularization for carotid pseudoaneurysm and patch degeneration after carotid endarterectomy
por: Aru, Roberto G., et al.
Publicado: (2023)

Magnetic resonance imaging and clinical outcome in patients with symptomatic carotid artery stenosis after carotid artery revascularization
por: Badacz, Rafał, et al.
Publicado: (2017)

Transposition of the persistent sciatic artery for lower limb revascularization after resection of an embolizing proximal sciatic artery aneurysm
por: Feer, Rudolf, et al.
Publicado: (2017)

Carotid Artery Revascularization Improves Cardiac Sympathetic Nerve Activity in Patients With Carotid Artery Stenosis
por: Kato, Tsukasa, et al.
Publicado: (2022)

Open or endovascular revascularization in the treatment of acute lower limb ischaemia
por: Grip, O., et al.
Publicado: (2018)

Current Medical Therapy and Revascularization in Peripheral Artery Disease of the Lower Limbs: Impacts on Subclinical Chronic Inflammation
por: Cecchini, Andrea Leonardo, et al.
Publicado: (2023)

Estimated Cost of Transcarotid Arterial Revascularization Compared With Carotid Endarterectomy and Transfemoral Carotid Stenting
por: Kanitra, John J, et al.
Publicado: (2022)

Cognitive functions and patterns of brain activity in patients after simultaneous coronary and carotid artery revascularization
por: Tarasova, Irina, et al.
Publicado: (2023)

Long-Term Outcomes of Coronary and Carotid Artery Disease Revascularization in the FRIENDS Study
por: Tomai, Fabrizio, et al.
Publicado: (2019)

Midterm outcomes of simultaneous carotid revascularization combined with coronary artery bypass grafting
por: Jia, Songhao, et al.
Publicado: (2022)

Risk Factors for Fasciotomy After Revascularization for Acute Lower Limb Ischaemia
por: Karonen, Emil, et al.
Publicado: (2021)

Carotid artery calcific disease management strategies during transcarotid artery revascularization
por: Malgor, Rafael Demarchi, et al.
Publicado: (2021)

Association of chronic kidney disease with perioperative outcomes following acute lower limb revascularization()()()
por: Cho, Nam Yong, et al.
Publicado: (2022)

Carotid revascularization: risks and benefits
por: O’Brien, Marlene, et al.
Publicado: (2014)

Advantages of carotid revascularization in the elderly
por: Tromba, Luciana, et al.
Publicado: (2013)

Use of Transcarotid Artery Revascularization, Transfemoral Carotid Artery Stenting, and Carotid Endarterectomy in the US From 2015 to 2019
por: Stonko, David P., et al.
Publicado: (2022)

The prognostic role of RBP-4 and adiponectin in patients with peripheral arterial disease undergoing lower limb endovascular revascularization
por: Kadoglou, Nikolaos P. E., et al.
Publicado: (2021)

Arteriovenous fistula as adjuvant treatment in arterial revascularization of an at-risk limb
por: Giusti, Júlio César Gomes, et al.
Publicado: (2021)

Outcomes of Revascularization and Factors Associated With Major Amputation in Patients With Lower Limb Arterial Injury: A Single-Center Retrospective Analysis
por: Ali, Ghulam, et al.
Publicado: (2021)

Calling and Phasing of Single-Nucleotide and Structural Variants of the LDLR Gene Using Oxford Nanopore MinION
por: Nazarenko, Maria S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_eusmmfsbjocsij824v5lbjs9sb